International Journal of Epidemiology, ISSN 0300-5771, 10/2007, Volume 36, Issue 5, pp. 1009 - 1021
Background Single-dose nevirapine (NVP) is the main option for the prevention of mother-to-child transmission (PMTCT) of HIV-1 in countries with limited...
HIV-1 | Systematic review | PMTCT | Nevirapine resistance | Meta-analysis | COTE-DIVOIRE | meta-analysis | ANTIRETROVIRAL THERAPY | DRUG-RESISTANCE | systematic review | BREAST-MILK | WOMEN | PROPHYLAXIS | nevirapine resistance | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | INTRAPARTUM | IMMUNODEFICIENCY-VIRUS TYPE-1 | MUTATIONS | SUBTYPE-A | HIV Infections - prevention & control | Drug Administration Schedule | HIV-1 - drug effects | Humans | Drug Resistance, Viral | Nevirapine - therapeutic use | HIV-1 - genetics | Pregnancy | Pregnancy Complications, Infectious - drug therapy | Anti-HIV Agents - therapeutic use | Female | HIV Infections - drug therapy | HIV Infections - transmission | Reverse Transcriptase Inhibitors - therapeutic use | Infectious Disease Transmission, Vertical - prevention & control | Infant, Newborn | Life Sciences | Santé publique et épidémiologie
HIV-1 | Systematic review | PMTCT | Nevirapine resistance | Meta-analysis | COTE-DIVOIRE | meta-analysis | ANTIRETROVIRAL THERAPY | DRUG-RESISTANCE | systematic review | BREAST-MILK | WOMEN | PROPHYLAXIS | nevirapine resistance | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | INTRAPARTUM | IMMUNODEFICIENCY-VIRUS TYPE-1 | MUTATIONS | SUBTYPE-A | HIV Infections - prevention & control | Drug Administration Schedule | HIV-1 - drug effects | Humans | Drug Resistance, Viral | Nevirapine - therapeutic use | HIV-1 - genetics | Pregnancy | Pregnancy Complications, Infectious - drug therapy | Anti-HIV Agents - therapeutic use | Female | HIV Infections - drug therapy | HIV Infections - transmission | Reverse Transcriptase Inhibitors - therapeutic use | Infectious Disease Transmission, Vertical - prevention & control | Infant, Newborn | Life Sciences | Santé publique et épidémiologie
Journal Article
PLoS ONE, ISSN 1932-6203, 11/2018, Volume 13, Issue 11, p. e0206745
Aim Metabolic risk factors are poorly documented for the first generation of young adults who have lived with HIV since childhood. We compared their metabolic...
OBESITY | MYOCARDIAL-INFARCTION | ABNORMALITIES | ADOLESCENTS | MULTIDISCIPLINARY SCIENCES | SEX | HEALTH SURVEY ENNS | CORONARY-HEART-DISEASE | FRENCH NUTRITION | ASSOCIATION | CARDIOVASCULAR RISK | Logistic regression | Usage | HIV patients | Metabolic diseases | Research | Comparative analysis | Risk factors | Lipoproteins (low density) | Populations | Body weight | Standardization | Dyslipidemia | Cardiovascular disease | Confidence intervals | Body mass index | Human immunodeficiency virus--HIV | Blood pressure | Children | Cross sections | Lipoproteins (high density) | Antiretroviral drugs | Statistical analysis | Young adults | Nutrition | Abnormalities | Health risks | Data processing | Triglycerides | Regression analysis | Risk analysis | Patients | Cholesterol | Hip | Tobacco | Body mass | Socioeconomic factors | Body size | Insulin resistance | Adults | Metabolic disorders | Life Sciences | Santé publique et épidémiologie | HIV | Human immunodeficiency virus
OBESITY | MYOCARDIAL-INFARCTION | ABNORMALITIES | ADOLESCENTS | MULTIDISCIPLINARY SCIENCES | SEX | HEALTH SURVEY ENNS | CORONARY-HEART-DISEASE | FRENCH NUTRITION | ASSOCIATION | CARDIOVASCULAR RISK | Logistic regression | Usage | HIV patients | Metabolic diseases | Research | Comparative analysis | Risk factors | Lipoproteins (low density) | Populations | Body weight | Standardization | Dyslipidemia | Cardiovascular disease | Confidence intervals | Body mass index | Human immunodeficiency virus--HIV | Blood pressure | Children | Cross sections | Lipoproteins (high density) | Antiretroviral drugs | Statistical analysis | Young adults | Nutrition | Abnormalities | Health risks | Data processing | Triglycerides | Regression analysis | Risk analysis | Patients | Cholesterol | Hip | Tobacco | Body mass | Socioeconomic factors | Body size | Insulin resistance | Adults | Metabolic disorders | Life Sciences | Santé publique et épidémiologie | HIV | Human immunodeficiency virus
Journal Article
PLoS ONE, ISSN 1932-6203, 03/2012, Volume 7, Issue 3, p. e33690
Objective: We assessed the effect of HIV status disclosure on retention in care from initiation of antiretroviral therapy (ART) among HIV-infected children...
DIAGNOSIS | IMPACT | WORKERS | MULTIDISCIPLINARY SCIENCES | ADULTS | YOUTH | HEALTH | SOUTHERN AFRICA | ADHERENCE | CHILDREN | UGANDA | Awareness | HIV Infections - epidemiology | Humans | Proportional Hazards Models | Probability | HIV Infections - psychology | Male | Self Disclosure | Africa, Western - epidemiology | Young Adult | Adolescent | Adult | Anti-HIV Agents - therapeutic use | Female | HIV Infections - drug therapy | Retrospective Studies | Child | Pediatrics | Medical research | Youth | HIV patients | HIV (Viruses) | Fertility clinics | Highly active antiretroviral therapy | Analysis | Immunotherapy | Medicine, Experimental | Teenagers | HIV infection | Disclosure of information | Adolescence | Antiretroviral drugs | Therapy | Statistical analysis | Mortality | Retention | Antiretroviral therapy | CD4 antigen | Confidence intervals | Immunosuppression | Acquired immune deficiency syndrome--AIDS | Antiretroviral agents | Human immunodeficiency virus--HIV | Death | Children | Adolescents | AIDS | HIV | Acquired immune deficiency syndrome | Human immunodeficiency virus
DIAGNOSIS | IMPACT | WORKERS | MULTIDISCIPLINARY SCIENCES | ADULTS | YOUTH | HEALTH | SOUTHERN AFRICA | ADHERENCE | CHILDREN | UGANDA | Awareness | HIV Infections - epidemiology | Humans | Proportional Hazards Models | Probability | HIV Infections - psychology | Male | Self Disclosure | Africa, Western - epidemiology | Young Adult | Adolescent | Adult | Anti-HIV Agents - therapeutic use | Female | HIV Infections - drug therapy | Retrospective Studies | Child | Pediatrics | Medical research | Youth | HIV patients | HIV (Viruses) | Fertility clinics | Highly active antiretroviral therapy | Analysis | Immunotherapy | Medicine, Experimental | Teenagers | HIV infection | Disclosure of information | Adolescence | Antiretroviral drugs | Therapy | Statistical analysis | Mortality | Retention | Antiretroviral therapy | CD4 antigen | Confidence intervals | Immunosuppression | Acquired immune deficiency syndrome--AIDS | Antiretroviral agents | Human immunodeficiency virus--HIV | Death | Children | Adolescents | AIDS | HIV | Acquired immune deficiency syndrome | Human immunodeficiency virus
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 12/2009, Volume 49, Issue 12, pp. 1936 - 1945
Prevention of mother-to-child transmission (MTCT) of human immunodeficiency virus type 1 (HIV-1) remains a challenge in most resource-limited settings,...
Pregnancy | HIV/AIDS | Highly active antiretroviral therapy | Antiretrovirals | Disease transmission | HIV | AIDS | Infants | Children | Breastfeeding | HIV 1 | VIRAL LOAD | INFECTIOUS DISEASES | INFECTED MOTHERS | COTE-DIVOIRE | RANDOMIZED-TRIAL | MICROBIOLOGY | IMMUNOLOGY | POSTNATAL TRANSMISSION | SHORT-COURSE ZIDOVUDINE | SINGLE-DOSE NEVIRAPINE | DITRAME PLUS | VERTICAL TRANSMISSION | ORAL ZIDOVUDINE | Antiretroviral Therapy, Highly Active | HIV-1 | Acquired Immunodeficiency Syndrome - immunology | Breast Feeding - adverse effects | Humans | Pregnancy Complications, Infectious - drug therapy | Female | CD4 Lymphocyte Count | Health Resources | Infectious Disease Transmission, Vertical - prevention & control | Acquired Immunodeficiency Syndrome - drug therapy | Prevention | Antiviral agents | Care and treatment | Dosage and administration | Perinatal infection | HIV infection | drug therapy | Breast Feeding | Pregnancy Complications, Infectious | Infectious Disease Transmission, Vertical | prevention & control | Acquired Immunodeficiency Syndrome | adverse effects | immunology
Pregnancy | HIV/AIDS | Highly active antiretroviral therapy | Antiretrovirals | Disease transmission | HIV | AIDS | Infants | Children | Breastfeeding | HIV 1 | VIRAL LOAD | INFECTIOUS DISEASES | INFECTED MOTHERS | COTE-DIVOIRE | RANDOMIZED-TRIAL | MICROBIOLOGY | IMMUNOLOGY | POSTNATAL TRANSMISSION | SHORT-COURSE ZIDOVUDINE | SINGLE-DOSE NEVIRAPINE | DITRAME PLUS | VERTICAL TRANSMISSION | ORAL ZIDOVUDINE | Antiretroviral Therapy, Highly Active | HIV-1 | Acquired Immunodeficiency Syndrome - immunology | Breast Feeding - adverse effects | Humans | Pregnancy Complications, Infectious - drug therapy | Female | CD4 Lymphocyte Count | Health Resources | Infectious Disease Transmission, Vertical - prevention & control | Acquired Immunodeficiency Syndrome - drug therapy | Prevention | Antiviral agents | Care and treatment | Dosage and administration | Perinatal infection | HIV infection | drug therapy | Breast Feeding | Pregnancy Complications, Infectious | Infectious Disease Transmission, Vertical | prevention & control | Acquired Immunodeficiency Syndrome | adverse effects | immunology
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 03/2011, Volume 55, Issue 3, pp. 1315 - 1317
Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit...
RESISTANCE | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | SINGLE | PHARMACOKINETICS | NEVIRAPINE | Emtricitabine | Adenine - analogs & derivatives | Deoxycytidine - analysis | Humans | Cote d'Ivoire | Adenine - analysis | Milk, Human - chemistry | Tenofovir | Anti-HIV Agents - analysis | Organophosphonates - analysis | Female | Deoxycytidine - analogs & derivatives | Infant, Newborn | Antiviral Agents
RESISTANCE | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | SINGLE | PHARMACOKINETICS | NEVIRAPINE | Emtricitabine | Adenine - analogs & derivatives | Deoxycytidine - analysis | Humans | Cote d'Ivoire | Adenine - analysis | Milk, Human - chemistry | Tenofovir | Anti-HIV Agents - analysis | Organophosphonates - analysis | Female | Deoxycytidine - analogs & derivatives | Infant, Newborn | Antiviral Agents
Journal Article
Trials, ISSN 1745-6215, 03/2017, Volume 18, Issue 1, pp. 141 - 8
Background: Irreversible pulpitis is a highly painful inflammatory condition of the dental pulp which represents a common dental emergency. Recommended care is...
Analgesia | Irreversible pulpitis | Corticosteroids | Pulpotomy | Pain management | Dental emergency | Mandibular molars | MEDICINE, RESEARCH & EXPERIMENTAL | INTRAOSSEOUS INJECTION | DOUBLE-BLIND | ANESTHETIC EFFICACY | Prednisolone - adverse effects | Prednisolone - administration & dosage | Humans | Middle Aged | Clinical Protocols | Pulpitis - physiopathology | Male | Pulpitis - diagnosis | Toothache - therapy | Dental Service, Hospital | Pulpitis - therapy | Toothache - physiopathology | Young Adult | Anti-Inflammatory Agents - adverse effects | Time Factors | Toothache - diagnosis | Adult | Anti-Inflammatory Agents - administration & dosage | Female | Pulpotomy - adverse effects | France | Drug Administration Schedule | Administration, Oral | Hospitals, University | Treatment Outcome | Adolescent | Molar - innervation | Aged | Pain Measurement | Emergency Medical Services | Research Design | Pulpitis | Treatment outcome | Usage | Care and treatment | Pain | Analysis | Dosage and administration | Research | Root canal therapy | Comparative analysis | Prednisolone | Life Sciences
Analgesia | Irreversible pulpitis | Corticosteroids | Pulpotomy | Pain management | Dental emergency | Mandibular molars | MEDICINE, RESEARCH & EXPERIMENTAL | INTRAOSSEOUS INJECTION | DOUBLE-BLIND | ANESTHETIC EFFICACY | Prednisolone - adverse effects | Prednisolone - administration & dosage | Humans | Middle Aged | Clinical Protocols | Pulpitis - physiopathology | Male | Pulpitis - diagnosis | Toothache - therapy | Dental Service, Hospital | Pulpitis - therapy | Toothache - physiopathology | Young Adult | Anti-Inflammatory Agents - adverse effects | Time Factors | Toothache - diagnosis | Adult | Anti-Inflammatory Agents - administration & dosage | Female | Pulpotomy - adverse effects | France | Drug Administration Schedule | Administration, Oral | Hospitals, University | Treatment Outcome | Adolescent | Molar - innervation | Aged | Pain Measurement | Emergency Medical Services | Research Design | Pulpitis | Treatment outcome | Usage | Care and treatment | Pain | Analysis | Dosage and administration | Research | Root canal therapy | Comparative analysis | Prednisolone | Life Sciences
Journal Article
Journal of the International AIDS Society, ISSN 1758-2652, 07/2018, Volume 21, Issue 7, pp. e25157 - n/a
Introduction Disclosure of HIV status to HIV‐infected children and adolescents is a major care challenge. We describe current site characteristics related to...
counselling | disclosure | vertical HIV infection | site assessment | adolescents | low‐ and middle‐income countries | low- and middle-income countries | DIAGNOSIS | INFECTIOUS DISEASES | low-and middle-income countries | HEALTH | IMMUNOLOGY | Technology application | Care and treatment | Analysis | Youth | Teenagers | Research | Children | HIV infection | Health surveys | Health aspects | Risk factors | Infections | Disclosure | Epidemiology | Polls & surveys | Children & youth | Medicine | Consortia | Infectious diseases | Hospitals | Acquired immune deficiency syndrome--AIDS | Human immunodeficiency virus--HIV | Questionnaires | Counseling
counselling | disclosure | vertical HIV infection | site assessment | adolescents | low‐ and middle‐income countries | low- and middle-income countries | DIAGNOSIS | INFECTIOUS DISEASES | low-and middle-income countries | HEALTH | IMMUNOLOGY | Technology application | Care and treatment | Analysis | Youth | Teenagers | Research | Children | HIV infection | Health surveys | Health aspects | Risk factors | Infections | Disclosure | Epidemiology | Polls & surveys | Children & youth | Medicine | Consortia | Infectious diseases | Hospitals | Acquired immune deficiency syndrome--AIDS | Human immunodeficiency virus--HIV | Questionnaires | Counseling
Journal Article
Tropical Medicine & International Health, ISSN 1360-2276, 03/2014, Volume 19, Issue 3, pp. 246 - 255
Objective To estimate the prevalence of oral mucosal diseases and dental caries among HIV‐infected children receiving antiretroviral treatment (ART) in West...
HIV | Mali | antiretroviral therapy | Sénégal | Africa | oral health | Côte d'Ivoire | child | Child | Antiretroviral therapy | Oral health | PEDIATRIC HIV | Cote d'Ivoire | DENTAL-CARIES | TROPICAL MEDICINE | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | PROFILE | Senegal | OROFACIAL MANIFESTATIONS | Anti-Retroviral Agents - therapeutic use | Confidence Intervals | Mouth Diseases - virology | Cross-Sectional Studies | HIV Infections - epidemiology | Humans | Child, Preschool | Logistic Models | Male | CD4 Lymphocyte Count | Parotid Gland - pathology | Disease Progression | Oral Hygiene - statistics & numerical data | Africa, Western - epidemiology | HIV Infections - immunology | Mouth Diseases - epidemiology | Dental Caries - epidemiology | Adolescent | Female | HIV Infections - drug therapy | Odds Ratio | Mouth Diseases - pathology | Oral Health - statistics & numerical data | Highly active antiretroviral therapy | Antiviral agents | Dental caries | HIV patients | HIV (Viruses) | HIV infection | Antiretroviral drugs | Dental health | Human immunodeficiency virus--HIV | Mouth | Childrens health | Oral Health | Côte d’Ivoire
HIV | Mali | antiretroviral therapy | Sénégal | Africa | oral health | Côte d'Ivoire | child | Child | Antiretroviral therapy | Oral health | PEDIATRIC HIV | Cote d'Ivoire | DENTAL-CARIES | TROPICAL MEDICINE | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | PROFILE | Senegal | OROFACIAL MANIFESTATIONS | Anti-Retroviral Agents - therapeutic use | Confidence Intervals | Mouth Diseases - virology | Cross-Sectional Studies | HIV Infections - epidemiology | Humans | Child, Preschool | Logistic Models | Male | CD4 Lymphocyte Count | Parotid Gland - pathology | Disease Progression | Oral Hygiene - statistics & numerical data | Africa, Western - epidemiology | HIV Infections - immunology | Mouth Diseases - epidemiology | Dental Caries - epidemiology | Adolescent | Female | HIV Infections - drug therapy | Odds Ratio | Mouth Diseases - pathology | Oral Health - statistics & numerical data | Highly active antiretroviral therapy | Antiviral agents | Dental caries | HIV patients | HIV (Viruses) | HIV infection | Antiretroviral drugs | Dental health | Human immunodeficiency virus--HIV | Mouth | Childrens health | Oral Health | Côte d’Ivoire
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 06/2011, Volume 55, Issue 6, pp. 2961 - 2967
Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit...
TRANSMISSION | METABOLITES | REVERSE-TRANSCRIPTASE INHIBITORS | PHOSPHORYLATION | POPULATION PHARMACOKINETICS | CARBOVIR TRIPHOSPHATE | DIPHOSPHATE | DISOPROXIL FUMARATE | EMTRICITABINE | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | LAMIVUDINE TRIPHOSPHATE | HIV-1 | Adenine - analogs & derivatives | Humans | Adenine - pharmacokinetics | Acquired Immunodeficiency Syndrome - drug therapy | Organophosphonates - pharmacokinetics | Pregnancy | Tenofovir | Infant, Newborn - metabolism | Anti-HIV Agents - pharmacokinetics | Pregnancy Complications, Infectious - drug therapy | Female | Infectious Disease Transmission, Vertical - prevention & control | Pharmacology
TRANSMISSION | METABOLITES | REVERSE-TRANSCRIPTASE INHIBITORS | PHOSPHORYLATION | POPULATION PHARMACOKINETICS | CARBOVIR TRIPHOSPHATE | DIPHOSPHATE | DISOPROXIL FUMARATE | EMTRICITABINE | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | LAMIVUDINE TRIPHOSPHATE | HIV-1 | Adenine - analogs & derivatives | Humans | Adenine - pharmacokinetics | Acquired Immunodeficiency Syndrome - drug therapy | Organophosphonates - pharmacokinetics | Pregnancy | Tenofovir | Infant, Newborn - metabolism | Anti-HIV Agents - pharmacokinetics | Pregnancy Complications, Infectious - drug therapy | Female | Infectious Disease Transmission, Vertical - prevention & control | Pharmacology
Journal Article
Journal of Clinical Periodontology, ISSN 0303-6979, 10/2018, Volume 45, Issue 10, pp. 1150 - 1163
Aim To assess whether periodontal treatment can lead to clinical, glycaemic control and quality of life improvements in metabolically unbalanced diabetic...
diabetes mellitus | periodontal diseases | quality of life | periodontal medicine | periodontitis | randomized controlled trial | GLYCEMIC CONTROL | METAANALYSIS | CLINICAL-TRIAL | EFFICACY | VALIDATION | ORAL CONDITIONS | THERAPY | DISEASES | DENTISTRY, ORAL SURGERY & MEDICINE | HEALTH SURVEY SF-36 | QUALITY-OF-LIFE | Diabetics | Medical research | Care and treatment | Clinical trials | Glycosylated hemoglobin | Medicine, Experimental | Diabetes | Periodontitis | Antibiotics | Diabetes mellitus | Oral hygiene | Hemoglobin | Scaling | Patients | Quality of life
diabetes mellitus | periodontal diseases | quality of life | periodontal medicine | periodontitis | randomized controlled trial | GLYCEMIC CONTROL | METAANALYSIS | CLINICAL-TRIAL | EFFICACY | VALIDATION | ORAL CONDITIONS | THERAPY | DISEASES | DENTISTRY, ORAL SURGERY & MEDICINE | HEALTH SURVEY SF-36 | QUALITY-OF-LIFE | Diabetics | Medical research | Care and treatment | Clinical trials | Glycosylated hemoglobin | Medicine, Experimental | Diabetes | Periodontitis | Antibiotics | Diabetes mellitus | Oral hygiene | Hemoglobin | Scaling | Patients | Quality of life
Journal Article
British Journal of Clinical Pharmacology, ISSN 0306-5251, 12/2014, Volume 78, Issue 6, pp. 1378 - 1386
Aims The aims were to describe emtricitabine (FTC) pharmacokinetics in a large population of pregnant women during the different trimesters of pregnancy, and...
emtricitabine | pregnancy | population pharmacokinetics | Pregnancy | Population pharmacokinetics | SAFETY | QUANTIFICATION | COMBINATION | HEMODYNAMICS | PREDICTION | WOMEN | TENOFOVIR DISOPROXIL FUMARATE | PHARMACOLOGY & PHARMACY | STEADY-STATE | HEALTHY-VOLUNTEERS | KIDNEY | Emtricitabine | Deoxycytidine - pharmacokinetics | Glomerular Filtration Rate | Pregnancy - metabolism | Area Under Curve | Models, Biological | Humans | Creatinine - blood | Female | Deoxycytidine - analogs & derivatives | Antiviral agents | Pregnant women | Analysis | Pharmacokinetics
emtricitabine | pregnancy | population pharmacokinetics | Pregnancy | Population pharmacokinetics | SAFETY | QUANTIFICATION | COMBINATION | HEMODYNAMICS | PREDICTION | WOMEN | TENOFOVIR DISOPROXIL FUMARATE | PHARMACOLOGY & PHARMACY | STEADY-STATE | HEALTHY-VOLUNTEERS | KIDNEY | Emtricitabine | Deoxycytidine - pharmacokinetics | Glomerular Filtration Rate | Pregnancy - metabolism | Area Under Curve | Models, Biological | Humans | Creatinine - blood | Female | Deoxycytidine - analogs & derivatives | Antiviral agents | Pregnant women | Analysis | Pharmacokinetics
Journal Article
Journals of Gerontology - Series A Biological Sciences and Medical Sciences, ISSN 1079-5006, 07/2017, Volume 72, Issue 7, pp. 951 - 957
Poor oral health has been associated with some components of frailty. The objective of this study was to identify the association between clinical measures of...
Frailty | Tooth loss | Cohort | Periodontitis | Oral health | Incidence | COUNTRIES | WEIGHT-LOSS | PREVALENCE | PERIODONTAL-DISEASE | GERIATRICS & GERONTOLOGY | COMMUNITY | GERONTOLOGY | PEOPLE | HEALTH | HYPERTENSION | VALIDITY | Risk Assessment | Health Status Disparities | Mexico - epidemiology | Humans | Risk Factors | Male | Statistics as Topic | Mouth Diseases - epidemiology | Frail Elderly - statistics & numerical data | Aged, 80 and over | Geriatric Assessment - methods | Aged | Oral Health - statistics & numerical data | Frail elderly | Demographic aspects | Health aspects
Frailty | Tooth loss | Cohort | Periodontitis | Oral health | Incidence | COUNTRIES | WEIGHT-LOSS | PREVALENCE | PERIODONTAL-DISEASE | GERIATRICS & GERONTOLOGY | COMMUNITY | GERONTOLOGY | PEOPLE | HEALTH | HYPERTENSION | VALIDITY | Risk Assessment | Health Status Disparities | Mexico - epidemiology | Humans | Risk Factors | Male | Statistics as Topic | Mouth Diseases - epidemiology | Frail Elderly - statistics & numerical data | Aged, 80 and over | Geriatric Assessment - methods | Aged | Oral Health - statistics & numerical data | Frail elderly | Demographic aspects | Health aspects
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 06/2011, Volume 55, Issue 6, pp. 2953 - 2960
Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit...
LAMIVUDINE | CELLS | ANTIRETROVIRAL DRUGS | REVERSE-TRANSCRIPTASE INHIBITORS | PHARMACOKINETICS | DISOPROXIL FUMARATE | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | INFECTED PATIENTS | HEALTHY-VOLUNTEERS | COMBINATION | TENOFOVIR | Emtricitabine | HIV-1 | Phosphorylation | Adenine - analogs & derivatives | Prospective Studies | Maternal-Fetal Exchange | Deoxycytidine - administration & dosage | Humans | Antiviral Agents - metabolism | Acquired Immunodeficiency Syndrome - drug therapy | Adenine - administration & dosage | Pregnancy | Tenofovir | Organophosphonates - administration & dosage | Deoxycytidine - metabolism | Infant, Newborn - metabolism | Pregnancy Complications, Infectious - drug therapy | Adult | Female | Infectious Disease Transmission, Vertical - prevention & control | Deoxycytidine - analogs & derivatives | Life Sciences | Human health and pathology | Pharmacology
LAMIVUDINE | CELLS | ANTIRETROVIRAL DRUGS | REVERSE-TRANSCRIPTASE INHIBITORS | PHARMACOKINETICS | DISOPROXIL FUMARATE | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | INFECTED PATIENTS | HEALTHY-VOLUNTEERS | COMBINATION | TENOFOVIR | Emtricitabine | HIV-1 | Phosphorylation | Adenine - analogs & derivatives | Prospective Studies | Maternal-Fetal Exchange | Deoxycytidine - administration & dosage | Humans | Antiviral Agents - metabolism | Acquired Immunodeficiency Syndrome - drug therapy | Adenine - administration & dosage | Pregnancy | Tenofovir | Organophosphonates - administration & dosage | Deoxycytidine - metabolism | Infant, Newborn - metabolism | Pregnancy Complications, Infectious - drug therapy | Adult | Female | Infectious Disease Transmission, Vertical - prevention & control | Deoxycytidine - analogs & derivatives | Life Sciences | Human health and pathology | Pharmacology
Journal Article